Yuqin Wang1, Baochan Wang, Feng Shen, Jiangao Fan, Haixia Cao. 1. Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, People's Republic of China.
Abstract
BACKGROUND: Questions remain about the dose-response relationship between body mass index (BMI) and primary liver cancer (PLC) risk, possible confounding by hepatitis virus infection, and differences by gender or geographic location. We performed a meta-analysis of prospective studies to explore these issues. METHODS: We searched PubMed and Embase for studies of BMI and risk of PLC through November 30, 2011. Summary relative risks with their corresponding 95% confidence intervals (CIs) were calculated using a random effects model. RESULTS: A total of 21 prospective studies (including 17,624 PLC cases) were included in our analysis. The summary relative risk for a 5-unit increment in BMI (in kg/m(2)) was 1.39 (95% CI: 1.25-1.55), with high heterogeneity. These positive results were robust when stratified by sex, geographic location, ascertainment of exposure and outcome, the number of cases, duration of follow-up, sample source, and cofounders. There was evidence of a nonlinear association between BMI and PLC risk, with the most pronounced increase in risk among persons with a BMI >32 kg/m(2). Patients with hepatitis C virus or cirrhosis (but not patients with hepatitis B virus) with excess weight had a higher risk of PLC development than general populations with excess weight. CONCLUSION: Excess weight increases PLC risk. For people with HCV infection or cirrhosis, risk increases are greater than for general population.
BACKGROUND: Questions remain about the dose-response relationship between body mass index (BMI) and primary liver cancer (PLC) risk, possible confounding by hepatitis virus infection, and differences by gender or geographic location. We performed a meta-analysis of prospective studies to explore these issues. METHODS: We searched PubMed and Embase for studies of BMI and risk of PLC through November 30, 2011. Summary relative risks with their corresponding 95% confidence intervals (CIs) were calculated using a random effects model. RESULTS: A total of 21 prospective studies (including 17,624 PLC cases) were included in our analysis. The summary relative risk for a 5-unit increment in BMI (in kg/m(2)) was 1.39 (95% CI: 1.25-1.55), with high heterogeneity. These positive results were robust when stratified by sex, geographic location, ascertainment of exposure and outcome, the number of cases, duration of follow-up, sample source, and cofounders. There was evidence of a nonlinear association between BMI and PLC risk, with the most pronounced increase in risk among persons with a BMI >32 kg/m(2). Patients with hepatitis C virus or cirrhosis (but not patients with hepatitis B virus) with excess weight had a higher risk of PLC development than general populations with excess weight. CONCLUSION: Excess weight increases PLC risk. For people with HCV infection or cirrhosis, risk increases are greater than for general population.
Authors: D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker Journal: JAMA Date: 2000-04-19 Impact factor: 56.272
Authors: Timothy Wang; Yu Liu; Duke Letran; Julie Ha Thi Dang; Aaron M Harris; Chin-Shang Li; Moon S Chen; Christopher L Bowlus; Eric Chak Journal: J Community Health Date: 2020-04
Authors: Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn Journal: Cancer Res Date: 2016-10-15 Impact factor: 12.701
Authors: Arjun Gupta; Avash Das; Kaustav Majumder; Nivedita Arora; Helen G Mayo; Preet P Singh; Muhammad S Beg; Siddharth Singh Journal: Am J Clin Oncol Date: 2018-09 Impact factor: 2.339
Authors: Baharan Fekry; Aleix Ribas-Latre; Corrine Baumgartner; Alaa M T Mohamed; Mikhail G Kolonin; Frances M Sladek; Mamoun Younes; Kristin L Eckel-Mahan Journal: Cancer Res Date: 2019-10-01 Impact factor: 12.701
Authors: Jian Yin; Liang-Yu Yin; Neal D Freedman; Ting-Yuan Li; Sanford M Dawsey; Jian-Feng Cui; Philip R Taylor; Bin Liu; Jin-Hu Fan; Wen Chen; Christian C Abnet; You-Lin Qiao Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-08-20 Impact factor: 4.254